| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 5.2e-05 | 1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 9.9e-05 | 1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.00012 | 1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.00019 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.00022 | 1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.00044 | 1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.00043 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.0027 | 1 |